Astemizole promotes the anti-tumor effect of vitamin D through inhibiting miR-125a-5p-meidated regulation of VDR in HCC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Astemizole promotes the anti-tumor effect of vitamin D through inhibiting miR-125a-5p-meidated regulation of VDR in HCC

Published:2018-11 Issue: Volume:107 Page:1682-1691
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Xu Junli,Wang Yan,Zhang Ya,Dang Shan,He Shuixiang

Funder

Shaanxi Provincial Science and Technique developmental and Social Key Project

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference35 articles.

1. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis;El-Serag;Gastroenterology,2007

2. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int. J. Cancer,2010

3. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials;Llovet;Hepatology,1999

4. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications;Portolani;Ann. Surg.,2006

5. Aspirin minimized the pro-metastasis effect of sorafenib and improved survival by up-regulating HTATIP2 in hepatocellular carcinoma;Lu;PLoS One,2013

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum microRNA Profiles and Pathways in Hepatitis B-Associated Hepatocellular Carcinoma: A South African Study;International Journal of Molecular Sciences;2024-01-12

2. Vitamin D and microRNAs;Feldman and Pike' s Vitamin D;2024

3. Vitamin D, inflammation, and cancer;Feldman and Pike's Vitamin D;2024

4. Insights into the role of vitamin D in targeting the culprits of non-alcoholic fatty liver disease;Life Sciences;2023-11

5. PRIMA-1^MET Does Not Restore Vitamin D Sensitivity to MDA-MB-231 and MDA-MB-468 Triple-Negative Breast Cancer Cells;ACS Omega;2023-08-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3